Crescent Biopharma to Present at September Investor Conferences

Rhea-AI Summary

Crescent Biopharma (Nasdaq: CBIO), a biotechnology company focused on cancer therapies, has announced its participation in two major healthcare investor conferences in September 2025.

The company will participate in a fireside chat at the Cantor Global Healthcare Conference on September 4, 2025, at 1:00 p.m. ET, and at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025, at 5:35 p.m. ET. Both events will take place in New York.

Webcasts will be available on the company's investor relations website, with replays accessible for 90 days.

News Market Reaction – CBIO

-0.70%

1 alert

-0.70% News Effect

-$1M Valuation Impact

$206M Market Cap

0.0x Rel. Volume

On the day this news was published, CBIO declined 0.70%, reflecting a mild negative market reaction. This price movement removed approximately $1M from the company's valuation, bringing the market cap to $206M at that time.

Data tracked by StockTitan Argus on the day of publication.

WALTHAM, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in September:

• Cantor Global Healthcare Conference 2025, fireside chat on Thursday, September 4, 2025, at 1:00 p.m. ET in New York.
  

• Morgan Stanley 23^rd Annual Global Healthcare Conference, fireside chat on Monday, September 8, 2025, at 5:35 p.m. ET in New York.
  

A live webcast of each presentation will be available in the Investors section of the Company's website at https://investors.crescentbiopharma.com/news-events/events, and a replay will be accessible for 90 days.

About Crescent Biopharma
Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors. For more information, visit www.crescentbiopharma.com and follow the Company on LinkedIn and X.

Contact
Amy Reilly
Chief Communications Officer
amy.reilly@crescentbiopharma.com
617-465-0586

FAQ

When is Crescent Biopharma (CBIO) presenting at the Cantor Global Healthcare Conference 2025?

Crescent Biopharma will present at the Cantor Global Healthcare Conference through a fireside chat on Thursday, September 4, 2025, at 1:00 p.m. ET in New York.

What time is Crescent Biopharma's presentation at the Morgan Stanley Healthcare Conference?

Crescent Biopharma will present at the Morgan Stanley Global Healthcare Conference through a fireside chat on Monday, September 8, 2025, at 5:35 p.m. ET in New York.

Where can I watch Crescent Biopharma's (CBIO) investor conference presentations?

The presentations can be watched via live webcast in the Investors section of Crescent Biopharma's website at investors.crescentbiopharma.com, with replays available for 90 days.

Which investor conferences is Crescent Biopharma (CBIO) attending in September 2025?

Crescent Biopharma is attending two conferences: the Cantor Global Healthcare Conference on September 4 and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025.